XFOR · X4 Pharmaceuticals, Inc
$3.95
+0.02 (+0.51%)
At close · Jul 29
Market Cap
$370.68M
Shares
94.32M
X4 Pharmaceuticals, Inc Earnings Call Transcripts
Every quarterly earnings call for X4 Pharmaceuticals, Inc (XFOR) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
·
$
−$19.64M
'21 Q2
21-08-03
·
$
−$20.18M
'21 Q3
21-11-04
·
$
−$30.21M
'21 Q4
22-01-25
·
$
−$55.71M
'23 Q2
23-08-10
·
$
−$2.31M
'23 Q3
23-11-09
·
$
−$51.77M
'24 Q1
24-05-07
·
$563,000
$90.83M
'24 Q2
24-08-08
·
$560,000
−$36.70M
'24 Q3
24-11-13
·
$1.48M
−$39.82M
'24 Q4
25-03-25
LATEST
·
$900,000
$282,000
'25 Q1
25-05-01
Conference
Investor event
2026-06-04
2026 Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q1
2025-05-01
X4 Pharmaceuticals, Inc Q1 FY2025 Earnings Call
Confident tone
XOLREMDI commercialization in WHIM
4WARD Phase 3 trial in chronic neutropenia
Regulatory and global expansion
Revenue
$900,000
Diluted EPS
$0.04
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-25
X4 Pharmaceuticals, Inc Q4 FY2024 Earnings Call
Revenue
$1.48M*
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-13
X4 Pharmaceuticals, Inc Q3 FY2024 Earnings Call
Positive tone
Phase II mavorixafor chronic neutropenia data
G-CSF unmet need and dose reduction
XOLREMDI (mavorixafor) U.S. launch in WHIM
Revenue
$560,000
Diluted EPS
$-5.48
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
X4 Pharmaceuticals, Inc Q2 FY2024 Earnings Call
Revenue
$563,000
Diluted EPS
$13.57
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
X4 Pharmaceuticals, Inc Q1 FY2024 Earnings Call
Confident tone
Chronic Neutropenia (CN) Expansion Opportunity
WHIM Market Opportunity and Disease Awareness
G-CSF Combination and Dosing Management
Revenue
$
Diluted EPS
$-7.77
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-21
X4 Pharmaceuticals, Inc Q4 FY2023 Earnings Call
Confident tone
Chronic neutropenia program
WHIM NDA and PDUFA
Mavorixafor clinical profile
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-09
X4 Pharmaceuticals, Inc Q3 FY2023 Earnings Call
Revenue
$
Diluted EPS
$-0.30
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
X4 Pharmaceuticals, Inc Q2 FY2023 Earnings Call
Revenue
$
Diluted EPS
$-9.90
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
X4 Pharmaceuticals, Inc Q1 FY2023 Earnings Call
Diluted EPS
$-4.80
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-21
X4 Pharmaceuticals, Inc Q4 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
X4 Pharmaceuticals, Inc Q3 FY2022 Earnings Call
Diluted EPS
$-7.80
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
X4 Pharmaceuticals, Inc Q2 FY2022 Earnings Call
Diluted EPS
$-18.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-12
X4 Pharmaceuticals, Inc Q1 FY2022 Earnings Call
Diluted EPS
$-21.60
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-01-25
X4 Pharmaceuticals, Inc Q4 FY2021 Earnings Call
Revenue
$*
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
X4 Pharmaceuticals, Inc Q3 FY2021 Earnings Call
Revenue
$
Diluted EPS
$-22.80
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-03
X4 Pharmaceuticals, Inc Q2 FY2021 Earnings Call
Revenue
$
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
X4 Pharmaceuticals, Inc Q1 FY2021 Earnings Call
Revenue
$
▼ 100% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-04
X4 Pharmaceuticals, Inc Q4 FY2020 Earnings Call
Revenue
$*
Rev · 7q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
X4 Pharmaceuticals, Inc Q3 FY2020 Earnings Call
Revenue
$
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-30
X4 Pharmaceuticals, Inc Q2 FY2020 Earnings Call
Revenue
$
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
X4 Pharmaceuticals, Inc Q1 FY2020 Earnings Call
Revenue
$3.00M
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-12
X4 Pharmaceuticals, Inc Q4 FY2019 Earnings Call
Revenue
$*
▼ 100% YoY
Rev · 4q
Audio
Transcript
Slides
8-K10-K
Showing 1–23 of 23 earnings calls